Medallion Wealth Advisors’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Medallion Wealth Advisors's PGEN Position: Q2 2026 in Review
Medallion Wealth Advisors sold out of Precigen (PGEN) in Q2 2026, closing a stake of 50 shares — an estimated $194 sold.
Medallion Wealth Advisors first reported a position in PGEN in Q4 2024 and held it in 6 quarters. The position peaked at $209 in Q4 2025. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Medallion Wealth Advisors reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
- Medallion Wealth Advisors sold 50 Precigen shares in Q2 2026, an estimated $194.
- Medallion Wealth Advisors first reported a position in Precigen in Q4 2024 and held it in 6 quarters.
- Medallion Wealth Advisors's Precigen position peaked at $209 in Q4 2025.
- 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.